Opportunity Information: Apply for W81XWH 16 TSCRP SIDA
Apply for W81XWH 16 TSCRP SIDA
- The DOD-AMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on May 09, 2016 and posted on May 09, 2016.
- Applicants must submit their applications by Jul 18, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award (SIDA) is a Department of Defense Tuberous Sclerosis Complex Research Program (TSCRP) funding opportunity designed to push TSC research forward faster by requiring true collaboration. Offered for the first time in FY16, the award is built around the idea that certain breakthroughs are more likely when investigators from different backgrounds deliberately combine their strengths to attack a shared scientific problem, rather than working in parallel on loosely connected aims. The overall purpose aligns with the TSCRP vision to lessen the impact of tuberous sclerosis complex by supporting research that can meaningfully accelerate progress in the field.
A defining feature of this mechanism is that it must be led by a partnership of two or three Principal Investigators who jointly design and execute a single integrated project. The collaboration can be brand new or an expansion of an existing partnership, but it must be more than a convenience-based team-up. The application is expected to show that each investigator brings unique expertise, experience, or resources that are essential to success, and that the combined approach creates a clear synergy. In practical terms, reviewers are looking for a project where the outcomes can be achieved more rapidly and efficiently because the investigators are working together, and where those outcomes could not realistically be achieved by a single investigator working alone. Multidisciplinary approaches are explicitly encouraged, and teams can span institutions.
The opportunity is also positioned for ambitious, creative work, but it draws a line between innovation and simple extension of what is already known. The program recognizes that genuinely groundbreaking research can carry risk, yet it still expects the project to rest on a solid scientific foundation. That foundation should be demonstrated through logical reasoning, a critical analysis of the existing literature, and preliminary data that ties directly to TSC and to the proposed study. Innovation, in this context, is framed as work that introduces a new paradigm, challenges prevailing assumptions, reframes a persistent problem in a new way, or otherwise shows substantial originality. Projects described as incremental advances on already published data are not considered innovative for this mechanism.
In terms of team structure and submission logistics, one investigator is designated as the Initiating PI. This person serves as the main administrative lead for the submission process. The other investigator(s) participate as Partnering PI(s). While Initiating and Partnering PIs have different submission requirements (referenced as being detailed elsewhere in the full announcement), the expectation is that all PIs contribute in a meaningful way to the planning and execution of the work. If the project is selected for funding, each PI receives his or her own award, which reinforces the model of shared leadership and shared accountability across the collaboration.
Because the program is specifically trying to fund high-functioning collaborations, applications are expected to spell out how the team will actually operate. Each proposed study must include clear interaction plans covering communication routines, coordination of research activities, tracking and sharing of progress and results, and procedures for data transfer. For multi-institutional projects, there is an additional requirement: an intellectual property plan. That plan is meant to address potential intellectual and material property issues early, reduce institutional friction, and remove barriers that could undermine cooperation or delay progress, all with the goal of protecting the collaboration and keeping the project moving.
Administratively, the opportunity is listed as W81XWH-16-TSCRP-SIDA and is offered by DOD-AMRAA. It falls under the Science and Technology and other Research and Development activity category (CFDA 12.420). The eligible applicant pool is described as unrestricted, meaning it is broadly open to many entity types, subject to any clarifications in the full eligibility section of the announcement. The funding instrument types include cooperative agreements and grants. The posting date and creation date were May 9, 2016, with an application closing date of July 18, 2016. The notice indicates an expectation of one award, and the award ceiling is not specified in the provided source text.
Frequently Asked Questions (FAQs): FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award (SIDA)
What is the FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award (SIDA)?
The FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award (SIDA) is a funding opportunity under the Department of Defense (DoD) Tuberous Sclerosis Complex Research Program (TSCRP). It is designed to speed progress in tuberous sclerosis complex (TSC) research by requiring true collaboration through a single, integrated project led by a team of two or three Principal Investigators (PIs).
What is the main purpose of this award?
The purpose is to push TSC research forward faster by supporting collaborative research that can meaningfully accelerate progress in the field. The award aligns with the TSCRP vision to lessen the impact of tuberous sclerosis complex.
What makes this funding mechanism different from typical multi-PI projects?
This mechanism is built around deliberate synergy rather than parallel work on loosely connected aims. Reviewers expect a single integrated project where each PI brings unique expertise, experience, or resources that are essential to success, and where the combined approach achieves outcomes more rapidly and efficiently than any one investigator could alone.
How many Principal Investigators are required?
The project must be led by a partnership of two or three Principal Investigators who jointly design and execute one integrated project.
Can collaborators be from different institutions?
Yes. Multidisciplinary approaches are explicitly encouraged, and teams can span institutions.
Does the collaboration need to be new?
No. The collaboration can be brand new or an expansion of an existing partnership. However, it must be more than a convenience-based team-up; the application is expected to demonstrate real synergy and complementary roles.
What does the program mean by "synergy" in this context?
Synergy means the investigators are combining strengths in a way that creates a clear advantage: outcomes can be achieved more rapidly and efficiently because the team is working together, and those outcomes could not realistically be achieved by a single investigator working alone.
What kind of research does SIDA aim to support?
The opportunity is positioned for ambitious, creative work that meaningfully accelerates progress in TSC. It recognizes that groundbreaking research can carry risk, but it still expects a solid scientific foundation.
How is "innovation" defined for this opportunity?
Innovation is framed as work that introduces a new paradigm, challenges prevailing assumptions, reframes a persistent problem in a new way, or otherwise shows substantial originality. The program draws a line between innovation and simple extension of what is already known.
Are incremental or straightforward extensions of published work allowed?
Projects described as incremental advances on already published data are not considered innovative for this mechanism, based on the description provided.
What scientific foundation is expected in the application?
The project should rest on a solid scientific foundation demonstrated through logical reasoning, a critical analysis of existing literature, and preliminary data that ties directly to tuberous sclerosis complex (TSC) and to the proposed study.
What roles exist within the PI team?
One investigator is designated as the Initiating PI, serving as the main administrative lead for the submission process. The other investigator(s) participate as Partnering PI(s). The opportunity notes that Initiating and Partnering PIs have different submission requirements referenced in the full announcement, and that all PIs are expected to contribute meaningfully to planning and execution.
How are awards issued if the project is funded?
If selected for funding, each PI receives his or her own award. This structure is intended to reinforce shared leadership and shared accountability across the collaboration.
What operational planning is required for the collaboration?
Applications are expected to explain how the team will operate, including clear interaction plans covering communication routines, coordination of research activities, tracking and sharing of progress and results, and procedures for data transfer.
Is an intellectual property (IP) plan required?
Yes, for multi-institutional projects there is an additional requirement for an intellectual property plan. The plan is meant to address potential intellectual and material property issues early, reduce institutional friction, and remove barriers that could undermine cooperation or delay progress.
What is the opportunity number (announcement identifier)?
The opportunity is listed as W81XWH-16-TSCRP-SIDA.
Which organization is offering this opportunity?
The notice indicates it is offered by DOD-AMRAA under the Department of Defense Tuberous Sclerosis Complex Research Program (TSCRP).
What is the activity category and CFDA number listed?
The activity category is listed as Science and Technology and other Research and Development, and the CFDA number provided is 12.420.
Who is eligible to apply?
The eligible applicant pool is described as unrestricted, meaning it is broadly open to many entity types, subject to any clarifications in the full eligibility section of the announcement.
What funding instrument types are available under this opportunity?
The funding instrument types include cooperative agreements and grants.
When was this opportunity posted, and when does it close?
The posting date and creation date are both listed as May 9, 2016. The application closing date is July 18, 2016.
How many awards are expected?
The notice indicates an expectation of one award.
What is the maximum award amount (award ceiling)?
The award ceiling is not specified in the provided source text.
Was this award offered previously?
It was offered for the first time in FY16, according to the provided description.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD Neurofibromatosis Investigator-Initiated Research Award
Previous opportunity: Impact of Aging in Human Cell Models of Alzheimer's Disease (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 16 TSCRP SIDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 16 TSCRP SIDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Neurofibromatosis Investigator-Initiated Research Award Apply for W81XWH 16 NFRP IIRA Funding Number: W81XWH 16 NFRP IIRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis Clinical Trial Award Apply for W81XWH 16 NFRP CTA Funding Number: W81XWH 16 NFRP CTA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Tuberous Sclerosis Complex Postdoctoral Development Award Apply for W81XWH 16 TSCRP PDA Funding Number: W81XWH 16 TSCRP PDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| NSF/DOE Partnership in Basic Plasma Science and Engineering Apply for 16 564 Funding Number: 16 564 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $250,000 |
| Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development Apply for 2016 NIST NICE 01 Funding Number: 2016 NIST NICE 01 Agency: DOC-NIST Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Enhance the Ability of Emergency Medical Services (EMS) to transport patients with highly infectious diseases (HID) Apply for EP IDS 16 003 Funding Number: EP IDS 16 003 Agency: HHS-OS-ASPR Category: Science and Technology and other Research and Development Funding Amount: $350,000 |
| TRADES Apply for DARPA BAA 16 39 Funding Number: DARPA BAA 16 39 Agency: DOD-DARPA-DSO Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Small Business Innovation Research Program (SBIR) Phase II 93.433 HHS/ACL/NIDILRR Apply for HHS 2016 ACL NIDILRR BISB 0182 Funding Number: HHS 2016 ACL NIDILRR BISB 0182 Agency: HHS-ACL Category: Science and Technology and other Research and Development Funding Amount: $575,000 |
| AAAS Science and Technology Policy Fellowships Apply for P16AS00159 Funding Number: P16AS00159 Agency: DOI-NPS Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Early Stage Innovations (ESI) Apply for NNH16ZOA001N 16ESI B2 Funding Number: NNH16ZOA001N 16ESI B2 Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| DoD Gulf War Illness Clinical Partnership Award Apply for W81XWH 16 GWIRP CPA Funding Number: W81XWH 16 GWIRP CPA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness Treatment Evaluation Award Apply for W81XWH 16 GWIRP TEA Funding Number: W81XWH 16 GWIRP TEA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness Epidemiology Research Award Apply for W81XWH 16 GWIRP GWIERA Funding Number: W81XWH 16 GWIRP GWIERA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness New Investigator Award Apply for W81XWH 16 GWIRP NIA Funding Number: W81XWH 16 GWIRP NIA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Investigator-Initiated Apply for W81XWH 16 SCIRP IIRA Funding Number: W81XWH 16 SCIRP IIRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Spinal Cord Injury Translational Award Apply for W81XWH 16 SCIRP TRA Funding Number: W81XWH 16 SCIRP TRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness Investigator-Initiated Focused Research Award Apply for W81XWH 16 GWIRP IIRFA Funding Number: W81XWH 16 GWIRP IIRFA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Psychological Health/Traumatic Brain Injury Cognitive Resilience and Readiness Research Award Apply for W81XWH 16 PHTBIRP CR3A Funding Number: W81XWH 16 PHTBIRP CR3A Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Computer and Information Science and Engineering (CISE) Research Initiation Initiative Apply for 16 565 Funding Number: 16 565 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $175,000 |
| ROSES 2016: Modeling, Analysis, and Prediction Apply for NNH16ZDA001N MAP Funding Number: NNH16ZDA001N MAP Agency: NASA-HQ Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 16 TSCRP SIDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
